Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus

BMC Chemical Biology

Volumn 9, Issue , 2009, Pages

  Pezacki, John Paul ^a,b   Sagan, Selena M ^a,b   Tonary, Angela M ^a   Rouleau, Yanouchka ^a   Bélanger, Sylvie ^a   Supekova, Lubica ^c   Su, Andrew I ^d  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; GAMMA INTERFERON; MESSENGER RNA; MEVALONIC ACID; RNA; SMALL INTERFERING RNA; TRANSCRIPTOME;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HUH7; CHIMPANZEE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE; GENE EXPRESSION PROFILING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INSIG 1 GENE; LIPID METABOLISM; LIVER CELL; NK 4 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROX 1 GENE; REPLICON; RNA FINGERPRINTING; TRANSLATION REGULATION; UBD GENE; UNINDEXED SEQUENCE; VIRUS REPLICATION;

HEPATITIS C VIRUS; PAN;

EID: 61849117274     PISSN: None     EISSN: 14726769     Source Type: Journal    
DOI: 10.1186/1472-6769-9-2     Document Type: Article

References (37)

1. Molecular Virology of Hepatitis C virus (HCV): 2006 Update. V Brass D Moradpour HE Blum, Int J Med Sci 2006 3 29 34 16614739
2. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. AJ Sanyal MJ Contos RK Sterling VA Luketic ML Shiffman RT Stravitz AS Mills, Am J Gastroenterol 2003 98 2064 2071 10.1111/j.1572-0241.2003.07640.x 14499789
3. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. A Lonardo LE Adinolfi P Loria N Carulli G Ruggiero CP Day, Gastroenterology 2004 126 586 597 10.1053/j.gastro.2003.11.020 14762795
4. The lipid droplet is an important organelle for hepatitis C virus production. Y Miyanari K Atsuzawa N Usuda K Watashi T Hishiki M Zayas R Bartenschlager T Wakita M Hijikata K Shimotohno, Nat Cell Biol 2007 9 961 969 10.1038/ncb1631 17643115
5. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. RG Hope J McLauchlin, J Gen Virol 2000 81 1913 1925 10900028
6. Intracellular imaging of HCV RNA and cellular lipids using simultaneous two-photon fluorescence and coherent anti-Stokes Raman scattering microscopies. X Nan AM Tonary A Stolow XS Xie JP Pezacki, ChemBioChem 2006 7 1895 1897 10.1002/cbic.200600330 17068839
7. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. K Moriya H Yotsuyanagi Y Shintani H Fujie K Ishibashi Y Matsuura T Miyamura K Koike, J Gen Virol 1997 78 1527 1531 9225025
8. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. SM Sagan Y Rouleau C Leggiadro L Supekova PG Schultz AI Su JP Pezacki, Biochem Cell Biol 2006 84 67 79 10.1139/O05-149 16462891
9. Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. S Grimbert D Pessayre C Degott JP Benhamou, Dig Dis Sci 1994 39 2032 2033 10.1007/BF02088142 8082513
10. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. M Ikeda K-I Abe M Yamada H Dansako K Naka N Kato, Hepatology 2006 44 117 125 10.1002/hep.21232 16799963
11. Genomic analysis of the host response to hepatitis C virus infection. AI Su JP Pezacki L Wodicka AD Brideau L Supekova R Thimme S Wieland J Bukh RH Purcell PG Schultz FV Chisari, Proc Natl Acad Sci USA 2002 99 15669 15674 12441396 10.1073/pnas.202608199
12. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. CM Adams J Reitz JK De Brabander JD Feramisco L Li MS Brown JL Goldstein, J Biol Chem 2004 279 52772 52780 10.1074/jbc.M410302200 15452130
13. Disruption of hepatitis C virus replication through inhibition of host protein geranylgeranylation. J Ye CF Wang R Sumpter MS Brown JL Goldstein M Gale, Proc Natl Acad Sci USA 2003 100 15865 15870 14668447 10.1073/pnas. 2237238100
14. Identification of FLB2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication. C Wang M Gale Jr BC Keller H Huang MS Brown JL Goldstein J Ye, Mol Cell 2005 18 425 434 10.1016/j.molcel.2005.04.004 15893726
15. Peroxisome proliferator-activated receptor α antagonism inhibits hepatitis C virus replication. B Rakic SM Sagan M Noestheden S Bélanger X Nan CL Evans XS Xie JP Pezacki, Chem Biol 2006 13 23 30 10.1016/j.chembiol. 2005.10.006 16426968
16. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. MW Smith ZN Yue MJ Korth HA Do L Boix N Fausto J Bruix RL Carithers Jr MG Katze, Hepatology 2003 38 1458 1467 14647057
17. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. MW Smith K-A Walters MJ Korth M Fitzgibbon S Proll JC Thompson MM Yeh MC Shuhart JC Furlong PP Cox DL Thomas JD Phillips JP Kushner N Fausto RL Carithers Jr MG Katze, Gastroenterology 2006 130 179 187 10.1053/j.gastro.2005.08.015 16401481
18. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. MW Smith ZN Yue GK Geiss NY Sadovnikova VS Carter L Boix CA Lazaro GB Rosenberg RE Bumgarner N Fausto J Bruix MG Katze, Cancer Res 2003 63 859 864 12591738
19. Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells. K Naka K-I Abe K Takemoto H Dansako M Ikeda K Shimotohno N Kato, J Hepatol 2006 44 869 878 10.1016/j.jhep.2006.01.030 16545484
20. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. L Chen I Borozan J Feld J Sun L-L Tannis C Coltescu J Heathcote AM Edwards ID McGilvray, Gastroenterology 2005 128 1437 1444 10.1053/j.gastro.2005.01.059 15887125
21. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. JJ Feld JH Hoofnagle, Nature 2005 436 967 972 10.1038/nature04082 16107837
22. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Körner J-O Koch U Herian L Theilmann R Bargenschlager, Science 1999 285 110 113 10.1126/science.285.5424.110 10390360
23. The hypercholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP. BA Janowski, Proc Natl Acad Sci USA 2002 99 12675 12680 12242342 10.1073/pnas.202471599
24. Mechanisms and significance of liver steatosis in hepatitis C virus infection. F Negro, World J GASTROENT 2006 12 6756 6765 17106922
25. Bleomycin is a potent small-molecule inhibitor of hepatitis C virus replication. B Rakic M Brûlotte Y Rouleau S Bélanger JP Pezacki, ChemBioChem 2006 7 1330 1333 10.1002/cbic.200600180 16888741
26. A Small-Molecule Probe for Hepatitis C Virus Replication that Blocks Protein Folding. B Rakic J Clarke T-L Tremblay J Taylor K Schreiber KM Nelson SR Abrams JP Pezacki, Chem Biol 2006 13 1051 1060 10.1016/j.chembiol.2006.08.010 17052609
27. Identification of Human Kinases Involved in Hepatitis C Virus Replication by Small Interference RNA Library Screening. L Supekova F Supek J Lee S Chen N Gray JP Pezacki A Schlapbach PG Schultz, J Biol Chem 2008 283 29 36 10.1074/jbc.M703988200 17951261
28. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. R Thimme J Bukh HC Spangenberg S Wieland J Pemberton C Steiger S Govindarajan RH Purcell FV Chisari, Proc Natl Acad Sci USA 2002 99 15661 15668 12441397 10.1073/pnas.202608299
29. Hepatocyte migration during liver development requires Prox1. B Sosa-Pineda JT Wigle G Oliver, Nat Genet 2000 25 254 255 10.1038/76996 10888866
30. A Prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4alpha that regulates the cholesterol 7alpha-hydroxylase gene. KH Song T Li JY Chiang, J Biol Chem 2006 281 10081 10088 16488887 10.1074/jbc.M513420200
31. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. CB Bigger KM Brasky RE Lanford, J Virol 2001 75 7059 7066 11435586 10.1128/JVI.75.15.7059-7066.2001
32. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. K Takaishi L Duplomb MY Wang J Li RH Unger, Proc Natl Acad Sci USA 2004 101 7106 7111 15096598 10.1073/pnas.0401715101
33. Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis. Y Gong JN Lee MS Brown JL Goldstein J Ye, Proc Natl Acad Sci USA 2006 103 6154 6159 16606821 10.1073/pnas.0601923103
34. Identification of a novel gene expressed in activated natural killer cells and T cells. CA Dahl RP Schall HL He JS Cairns, J Immun 1992 148 597 603 1729377
35. FAT10, a ubiquitin-independent signal for proteasomal degradation. MS Hipp B Kalveram S Raasi M Groettrup G Schmidtke, Mol Cell Biol 2005 25 3483 3291 15831455 10.1128/MCB.25.9.3483-3491.2005
36. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. S Raasi G Schmidtke R de Giuli M Groettrup, Eur J Immunol 1999 29 4030 4036 10.1002/(SICI)1521-4141(199912)29: 12<4030::AID-IMMU4030>3.0.CO;2-Y 10602013
37. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. CB Bigger B Guerra KM Brasky G Hubbard MR Beard BA Luxon SM Lemon RE Lanford, J Virol 2004 78 13779 13792 15564486 10.1128/JVI.78.24.13779- 13792.2004